Document Type : Research Articles
Authors
Ferdowsi University of Mashhad
Abstract
The prevalence of type 2 diabetes mellitus (T2DM) is rising dramatically in the Middle East, especially in the Islamic Republic of Iran, but the genetic basis of type 2 diabetes in Iran is poorly understood. Polymorphisms of hepatocyte nuclear factor-1α (HNF-1α) and glucagon-like peptide-1 receptor (GLP-1R) genes showed association with type 2 diabetes in several ethnic groups. In this study, we evaluated whether these markers confer susceptibility to T2DM in a diabetic population living in Mashhad (northeast of Iran). Genotyping of Ala98Val (HNF-1α) and Thr149Met (GLP-1R) was done by the restriction fragment length polymorphism-PCR (RFLP-PCR) method in the following groups: 1) early-onset diabetes (age at onset ≤ 35 years); 2) late-onset diabetes (age at onset > 35 years); and 3) control. Our results showed that CT (Ala/Val) genotype of HNF-1α was higher in the early-onset type 2 diabetic group compared to the controls but difference was not significant. We did not find the GLP-1R Thr149Met mutation in all participants. The prevalence of the HNF-1α (Ala98Val) and (GLP-1R) Thr149Met mutations has not been previously reported in Iranian participants. We conclude that these mutations are not a common cause of T2DM in our studied population.
Keywords
1- Anuradha S., Radha V., Deepa R., Hansen T., Carstensen B., Pedersen O. and Mohan V. (2005) A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians. Diabetes Care 28:2430-2435.
2- Association A. D. (2009) Diagnosis and Classification of Diabetes Mellitus Diabetes Care 32:S62–S67.
3- Azizi F., Gouya M. M., Vazirian P., Dolatshahi P. and Habibian S. (2003a) The diabetes prevention and control programme of the Islamic Republic of Iran. Eastern Mediterranean health journal 9:1114-1121.
4- Azizi F., Guoya M. M., Vazirian P., Dolatshati P. and Habbibian S. (2003b) Screening for type 2 diabetes in the Iranian national programme: a preliminary report. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 9:1122-1127.
5- Beinborn M., Worrall C. I., McBride E. W. and Kopin A. S. (2005) A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness. Regulatory peptides 130:1-6.
6- Bener A., Zirie M. and Al-Rikabi A. (2005) Genetics, obesity, and environmental risk factors associated with type 2 diabetes. Croatian medical journal 46:302-307.
7- Bowden D. W., Sale M., Howard T. D., Qadri A., Spray B. J., Rothschild C. B., Akots G., Rich S. S. and Freedman B. I. (1997) Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 46:882-886.
8- Chiu K. C., Chuang L. M., Chu A. and Wang M. (2003) Transcription factor 1 and beta-cell function in glucose-tolerant subjects. Diabetic medicine: Journal of the British Diabetic Association 20:225-230.
9- Drucker D. J. (2006) The biology of incretin hormones. Cell metabolism 3:153-165.
10- Drucker D. J. and Nauck M. A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696-1705.
11- Ellard S. (2000) Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Human mutation 16:377-385.
12- Gadsby R. (2002) Epidemiology of diabetes. Advance Drug Delivery Reviews 54:1165-1172.
13- Herman W. H., Fajans S. S., Ortiz F. J., Smith M. J., Sturis J., Bell G. I., Polonsky K. S. and Halter J. B. (1994) Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40-46.
14- Holmkvist J., Cervin C., Lyssenko V., Winckler W., Anevski D., Cilio C., Almgren P., Berglund G., Nilsson P., Tuomi T., Lindgren C. M., Altshuler D. and Groop L. (2006) Common variants in HNF-1 alpha and risk of type 2 diabetes. Diabetologia 49:2882-2891.
15- Hussain A., Vaaler S., Sayeed M. A., Mahtab H., Ali S. M. and Khan A. K. (2007) Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study. European journal of public health 17:291-296.
16- Iwasaki N., Oda N., Ogata M., Hara M., Hinokio Y., Oda Y., Yamagata K., Kanematsu S., Ohgawara H., Omori Y. and Bell G. I. (1997) Mutations in the hepatocyte nuclear factor-1alpha/MODY3 gene in Japanese subjects with early- and late-onset NIDDM. Diabetes 46:1504-1508.
17- Lee H. J., Ahn C. W., Kim S. J., Song Y. D., Lim S. K., Kim K. R., Lee H. C. and Huh K. B. (2001) Mutation in hepatocyte nuclear factor-1alpha is not a common cause of MODY and early-onset type 2 diabetes in Korea. Acta diabetologica 38:123-127.
18- Lehto M., Wipemo C., Ivarsson S. A., Lindgren C., Lipsanen-Nyman M., Weng J., Wibell L., Widen E., Tuomi T. and Groop L. (1999) High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes. Diabetologia 42:1131-1137.
19- Lim D. M., Huh N. and Park K. Y. (2008) Hepatocyte nuclear factor 1-alpha mutation in normal glucose-tolerant subjects and early-onset type 2 diabetic patients. The Korean journal of internal medicine 23:165-169.
20- Mahtani M. M., Widen E., Lehto M., Thomas J., McCarthy M., Brayer J., Bryant B., Chan G., Daly M., Forsblom C., Kanninen T., Kirby A., Kruglyak L., Munnelly K., Parkkonen M., Reeve-Daly M. P., Weaver A., Brettin T., Duyk G., Lander E. S. and Groop L. C. (1996) Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature genetics 14:90-94.
21- Sahu R. P., Aggarwal A., Zaidi G., Shah A., Modi K., Kongara S., Aggarwal S., Talwar S., Chu S., Bhatia V. and Bhatia E. (2007) Etiology of early-onset type 2 diabetes in Indians: islet autoimmunity and mutations in hepatocyte nuclear factor 1alpha and mitochondrial gene. The Journal of clinical endocrinology and metabolism 92:2462-2467.
22- Sathananthan A., Man C. D., Micheletto F., Zinsmeister A. R., Camilleri M., Giesler P. D., Laugen J. M., Toffolo G., Rizza R. A., Cobelli C. and Vella A. (2010) Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care 33:2074-2076.
23- Shaw J., Lovelock P. K., Kesting J. B., Cardinal J., Duffy D., Wainwright B. and Cameron D. P. (1998) Novel susceptibility gene for late-onset NIDDM is localized to human chromosome 12q. Diabetes 47:1793-1796.
24- Tokuyama Y., Matsui K., Egashira T., Nozaki O., Ishizuka T. and Kanatsuka A. (2004) Five missense mutations in glucagon-like peptide 1 receptor gene in Japanese population. Diabetes research and clinical practice 66:63-69.
25- Urhammer S. A., Fridberg M., Hansen T., Rasmussen S. K., Moller A. M., Clausen J. O. and Pedersen O. (1997) A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 46:912-916.
26- Weedon M. N., Owen K. R., Shields B., Hitman G., Walker M., McCarthy M. I., Hattersley A. T. and Frayling T. M. (2005) A large-scale association analysis of common variation of the HNF1alpha gene with type 2 diabetes in the U.K. Caucasian population. Diabetes 54:2487-2491.
27- Winckler W., Burtt N. P., Holmkvist J., Cervin C., de Bakker P. I., Sun M., Almgren P., Tuomi T., Gaudet D., Hudson T. J., Ardlie K. G., Daly M. J., Hirschhorn J. N., Altshuler D. and Groop L. (2005) Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes. Diabetes 54:2336-2342.
28- Yaturu S., Bridges J. F. and Dhanireddy R. R. (2005) Preliminary evidence of genetic anticipation in type 2 diabetes mellitus. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 11:CR262-265.
29- Zhang Y., Cook J. T., Hattersley A. T., Firth R., Saker P. J., Warren-Perry M., Stoffel M. and Turner R. C. (1994) Non-linkage of the glucagon-like peptide 1 receptor gene with maturity onset diabetes of the young. Diabetologia 37:721-724.
)
Send comment about this article